Number of GPs in decline for first time in 50 years
May 8, 2019Manufacturing and Production, Research and Development GP, NHS, pharma, public health
The number of GPs has been in decline, year on year, since 2014. The decline marks the first sustained fall …
Mohammed Dar becomes third MedImmune exec to join Immunocore
May 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
MedImmune’s Vice President of Clincial Development Oncology, Mohammed Dar has joined British biotech Immunocore as the company’s new CMO. Dar …
ABPI names Novartis’ Haseeb Ahmad as new President
May 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma
The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …
Gilead’s CFO and Executive Vice President to depart in 2020
May 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma
Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …
Will mobile phones save the NHS?
May 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, feature, mhealth, mobile health, pharma
The NHS is sick. According to politicians and NHS chiefs, the cure involves a strong dose of mHealth. Louis Goss …
Astellas and Cytokinetics’ reldesemtiv falls short at Phase 2 in ALS
May 7, 2019Manufacturing and Production, Sales and Marketing Astellas, als, amyotrophic lateral sclerosis, cytokinetics, pharma
Cytokinetics has announced at the American Academy of Neurology (AAN) that its fast skeletal muscle troponin activator (FSTA) reldesemtiv fell …
Lundbeck acquire Abide Therapeutics in deal worth $400 million
May 7, 2019Manufacturing and Production, Sales and Marketing Abide Therapeutics, Lundbeck, endocannabinoid system, neuropathic pain, tourette's
Danish firm Lundbeck has agreed to acquire San Diego-based biotech Abide Therapeutics as part of a deal worth $400 million. …
GW Pharma’s Epidiolex scores in rare childhood onset epilepsy Phase 3 trial
May 7, 2019Manufacturing and Production, Sales and Marketing CBD, Epidiolex, GW Pharma, cannabidiol, cannabis, epilepsy, tsc
GW Pharma’s Epidiolex has shown positive Phase 3 trial results for the fifth time in a row, after meeting primary …
FDA approves first two drugs for transthyretin amyloid cardiomyopathy
May 7, 2019Manufacturing and Production, Sales and Marketing FDA, Pfizer, US, Vyndamax, Vyndaqel, pharma
The FDA has approved its first two therapies for the treatment of cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM), …
Health Secretary Matt Hancock says he will not rule out ‘compulsory vaccination’
May 7, 2019Manufacturing and Production, Sales and Marketing Matt Hancock, infectious diseases, pharma, public health, vaccines
Health Secretary Matt Hancock has said he would not rule out ‘compulsory vaccination,’ as he argued that those spreading anti-vaccine …
GSK and Innoviva’s triple asthma therapy Trelegy Ellipta impresses at Phase 3
May 3, 2019Medical Communications, Research and Development GSK, Innoviva, Trelegy, ellipta, pharma
GSK and partner Innoviva have lifted the curtain on new Phase 3 data for their single inhaler triple therapy Trelegy …
ABPI names Novartis’ Haseeb Ahmad as new President
May 3, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma
The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …
Top Ten most popular articles on Pharmafile.com this week!
May 3, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Gilead, autism, dementia, opioids, pharma
This week was marked by the failure of two Phase 3 trials after both Eli Lilly and Gilead suffered from …
Insys Therapeutics founder John Kapoor found guilty of bribing doctors
May 3, 2019Medical Communications Insys Therapeutics, John Kapoor, Subsys, fentanyl, opioid crisis, opioids, pharma
The founder of opioid drugmaker Insys Therapeutics has been found guilty of bribing doctors in order to persuade them to …
HIV cannot be transmitted when viral load is undetectable, study shows
May 3, 2019Medical Communications Art, HIV, U=U, anti-retroviral drugs, infectious diseases, pharma
The risk of transmitting HIV through gay sex when the infected partner’s HIV load has been fully supressed by antiretroviral …
Sanofi’s Dengvaxia becomes first FDA-approved dengue vaccine, but with caveats…
May 2, 2019Sales and Marketing FDA, Sanofi, dengue, dengvaxia, pharma
Sanofi has announced that the FDA has granted authorisation to its tetravalent vaccine Dengvaxia for prevention of dengue disease originating …
Allergan shareholders reject proposal to split roles of chairman and CEO
May 2, 2019Research and Development Allergan, Appaloosa, CEO, board of directors, hedge fund, pharma
Allergan shareholders have rejected a proposal to immediately separate the roles of CEO and chairman, both of which are currently …
Takeda opens R&D facility in San Diego, California
May 2, 2019Manufacturing and Production, Research and Development CNS, GI, Japan, Takeda, california, neuroscience, san diego
Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 …
Hormone-based therapies show promise in children and adults with autism
May 2, 2019Research and Development ASD, autism, pharma, vasopressin
A hormone-based therapy might improve social function in people with autism, according to the results of two separate clinical trials. …
Ambien and other insomnia meds to be labelled with black box warnings after sleepwalking deaths
May 2, 2019Medical Communications, Research and Development FDA, ambien, black box warning, insomnia, sleeping pills, warning label
The FDA has said that Ambien, and other insomnia medications, must be labelled with a ‘black box warning’ – the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
